Bingqing Xie

1.4k citations
52 papers · 845 indexed · h-index 15
Topics
Retinal Diseases and Treatments (8 papers)Gut microbiota and health (7 papers)Bioinformatics and Genomic Networks (6 papers)
Journals
Nucleic Acids ResearchSHILAP Revista de lepidopterologíaBlood
Partner nations
United StatesChinaIndia

In The Last Decade

Bingqing Xie

49 papers receiving 838 citations

Peers

Bingqing Xie
Comparison fields: 5 of 115
  • Molecular Biology 553
  • Cancer Research 102
  • Immunology 99
  • Oncology 80
  • Pulmonary and Respiratory Medicine 59
Replace Zhaoyang Wang with:
Zhaoyang Wang China
Daisuke Watanabe Japan
Yun Jung Choi South Korea
Deok-Hoon Kong South Korea
Zhenzhen Zhang China
Dongmei Zhang China
Anna Dittrich Germany
Bingqing Xie relative to Zhaoyang Wang China Zhaoyang Wang's profile →
Citations per field
00.5×1.5×
Zhaoyang Wang · 1×
Citations per year

Countries citing papers authored by Bingqing Xie

Since Specialization
Citations

This map shows the geographic impact of Bingqing Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingqing Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingqing Xie more than expected).

Fields of papers citing papers by Bingqing Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingqing Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingqing Xie. The network helps show where Bingqing Xie may publish in the future.

Co-authorship network of co-authors of Bingqing Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Bingqing Xie. A scholar is included among the top collaborators of Bingqing Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingqing Xie. Bingqing Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 2
4 12
5 9
6 4
7 2
8 1
9 23
10 5
11
Drug-Gene Association Analysis to Identify Novel AMD Therapeutics
1
12 55
13 22
14 101
15 66
16 36
17 1
18 33
19 10
20 7

About Bingqing Xie

Bingqing Xie is a scholar working on Ophthalmology, Neurology and Molecular Biology, having authored 52 papers that have together received 845 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (8 papers), Gut microbiota and health (7 papers) and Bioinformatics and Genomic Networks (6 papers). The work is most often cited by research in Molecular Biology (553 citations), Cancer Research (102 citations) and Ophthalmology (57 citations). Bingqing Xie has collaborated with scholars based in United States, China and India. Frequent co-authors include Sheng Wang, Anindita Basu, Heather Eckart, Xin Gao, Ramzan Umarov, Lihua Li, Yu Li, Ming Fan, Susan Olalekan and Dinanath Sulakhe. Their work appears in journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026